UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
Search results for:
pertuzumab-trastuzumab-hyaluronidase
pertuzumab-trastuzumab-hyaluronidase
| Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pertuzumab-Trastuzumab-Hyaluronidase-zzxf | SOLUTION, SUBCUTANEOUS | 60 mg-60 mg-2000 units/mL (600 mg-600 mg-20,000 units/10 mL) | ||||||||||||||
| Pertuzumab-Trastuzumab-Hyaluronidase-zzxf | SOLUTION, SUBCUTANEOUS | 80 mg-40 mg-2000 units/mL (1200 mg-600 mg-30,000 units/15 mL) |
Last updated: Jul. 19, 2023
- Black Box Warning: Cardiomyopathy, Embryo-Fetal Toxicity, and Pulmonary Toxicity
UNC Health
System Formulary Restriction:
Use of Phesgo injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Orders must be signed by a Hematology/Oncology Attending Physician
A benefits investigation must be completed prior to use
Med Center
UNC Medical Center Formulary Restrictions